Cancer Research The Future of Cancer Research: Science and Patient Impact  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 13, 780-783, November 1, 1953]
© 1953 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Feinstein, R. N.
Right arrow Articles by Ballin, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Feinstein, R. N.
Right arrow Articles by Ballin, J. C.

Carboxypeptidases and Carboxypeptidase Inhibitor in Tumor-bearing Animals. A Possible Blood Test for Neoplasia*

Robert N. Feinstein and John C. Ballin

( U.S. Air Force Radiation Laboratory and Departments of Biochemistry and Pharmacology, University of Chicago, Chicago, Ill.)

The enzyme-inhibitor system consisting of carboxypeptidase a (requiring cysteine), carboxypeptidase b (inhibited by cysteine), and simultaneously occurring inhibitors (CPaI and CPbI) of these two enzymes has been studied in a variety of normal and tumor tissues and in the blood of normal and tumor-bearing animals. Five different solid tumors of the mouse and rat have been found to be completely devoid of both enzymes and of both inhibitors. Two ascitic tumors of the mouse have been found free of both inhibitors but have been found to have both enzymes in the precipitate and none in the supernatant of homogenates of the ascitic cells centrifuged at high-speed. Of ten different normal tissues tested, nine had both enzymes in the supernatant, eight had CPaI in the precipitate, and none had CPbI. The ascitic fluid is the only tissue or fluid in which we have detected appreciable amounts of CPbI, and this was noted only erratically.

In contrast to normal rat and rabbit blood cells, we have found the blood cells of tumor-bearing animals to be essentially free of CPaI. This is suggested as a possible test for the presence of neoplasia.

* This study was supported by funds provided under contract AF-33(038)27353 with the USAF School of Aviation Medicine, Randolph Field, Texas.

Received 6/10/53.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1953 by the American Association for Cancer Research.